蒙药三联疗法治疗幽门螺杆菌感染性胃病临床疗效观察

Clinical Effect of Gastropathy Helicobacter Pylori Infection in Mongolian Medicine Triple Therapy

目的:探讨三联疗法治疗幽门螺杆菌感染性胃病的临床疗效。方法:选取幽门螺杆菌感染性胃病患者160例,随机分为观察组和对照组各80例。观察组患者采取蒙药三联疗法进行治疗,对照组患者采取传统三联疗法进行治疗,比较两组患者的治疗效果。结果:经过治疗,两组患者的临床症状、生命体征、幽门螺杆菌情况等表现均有不同程度的改变,且观察组总有效率为96.25%,明显优于对照组的81.25%,差异具有统计学意义(P<0.05)。结论:采取蒙药三联疗法治疗幽门螺杆菌感染性胃病疗效显著,治疗时间短,且不易复发,具有长久有效的治疗效果,值得临床推广应用。

ObjectiveTo investigate the clinical effect of the treatment of gastropathy Hdicobacter pylori infectiontriple therapy. Meth-ods： 160 cases of gastropathy Helicobacter pylori infected patients were randomly divided into observation group and control group, 80 casesin each group. The observation group used Mongolian medicine triple therapy treatment mode. The control group used the traditional tripletherapy treatment mode. Results：two patients were treated and the clinical symptoms, vital signs, Helicobacter pylori, etc. perform-ance change in different degree, and the total effective rate of observation group was 96.25%, and control group in the total efficien-cy is 81.25 %, therefore, two groups of patients comparison of Helicobacter pylori is a significant difference, with statistical signifi-cance（P〈0.05）. Conclusion：the effection of treatment with gastropathy Helicobacter pylori infection in Mongolian medicine tripletherapy was benefit, treatment time is short, and not easy to relapse, with long effective therapeutic effect.